NW Biotherapeutic Challenges Cancer With DC-Vax - Presented by: The Aol. On Network

05/01/13 Northwest Biotherapeutic's CEO, Linda Powers, discusses the company's DCVax® technology and weighs in on regulatory challenges in the industry.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.65 0.29 ▼ 1.82%
AAPL $ 109.27 1.10 ▼ 1.00%
AA $ 9.49 0.08 ▼ 0.84%
QQQ $ 102.16 1.23 ▼ 1.19%
XIV $ 22.75 1.78 ▼ 7.26%
MSFT $ 42.61 0.89 ▼ 2.05%
GE $ 24 0.51 ▼ 2.08%
MU $ 16.82 0.23 ▲ 1.39%

As of 9/4/2015, 04:15 PM